PLN705.00
1.54% today
Warsaw, Sep 16, 04:49 pm CET
ISIN
PLTRFRM00018
Symbol
NEU

Neuca Stock price

PLN710.00
+51.00 7.74% 1M
-81.05 10.25% 6M
-142.58 16.72% YTD
-103.51 12.72% 1Y
+66.93 10.41% 3Y
+260.16 57.83% 5Y
+414.76 140.48% 10Y
+683.53 2,582.31% 20Y
Warsaw, Closing price Tue, Sep 16 2025
-6.00 0.84%
ISIN
PLTRFRM00018
Symbol
NEU

Key metrics

Basic
Market capitalization
PLN3.2b
Enterprise Value
PLN3.6b
Net debt
PLN448.2m
Cash
PLN154.0m
Shares outstanding
4.5m
Valuation (TTM | estimate)
P/E
24.3 | 19.4
P/S
0.2 | 0.2
EV/Sales
0.3 | 0.3
EV/FCF
30.8
P/B
3.0
Dividends
DPS
PLN16.00
Yield 1Y | 5Y
2.2% | 1.9%
Growth 1Y | 5Y
10.3% | 13.1%
Payout 1Y | 3Y
47.0% | 45.1%
Increased
19 Years
Financials (TTM | estimate)
Revenue
PLN13.0b | PLN13.4b
EBITDA
PLN372.6m | PLN515.8m
EBIT
PLN249.0m | PLN279.4m
Net Income
PLN135.4m | PLN165.1m
Free Cash Flow
PLN117.6m
Growth (TTM | estimate)
Revenue
7.6% | 6.1%
EBITDA
-7.7% | 30.4%
EBIT
-12.7% | 1.5%
Net Income
-17.7% | 7.1%
Free Cash Flow
-46.6%
Margin (TTM | estimate)
Gross
11.4%
EBITDA
2.9% | 3.9%
EBIT
1.9%
Net
1.0% | 1.2%
Free Cash Flow
0.9%
Financial Health
Equity Ratio
20.7%
Return on Equity
13.5%
ROCE
15.8%
ROIC
9.6%
Debt/Equity
0.6
More
EPS
PLN29.5
FCF per Share
PLN26.3
Short interest
-
Employees
5k
Rev per Employee
PLN2.7m
Show more

Is Neuca a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,016 stocks worldwide.

Neuca Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Neuca forecast:

1x Buy
10%
4x Hold
40%
5x Sell
50%

Analyst Opinions

10 Analysts have issued a Neuca forecast:

Buy
10%
Hold
40%
Sell
50%

Financial data from Neuca

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
13,040 13,040
8% 8%
100%
- Direct Costs 11,552 11,552
8% 8%
89%
1,488 1,488
7% 7%
11%
- Selling and Administrative Expenses 1,229 1,229
10% 10%
9%
- Research and Development Expense - -
-
-
373 373
8% 8%
3%
- Depreciation and Amortization 124 124
4% 4%
1%
EBIT (Operating Income) EBIT 249 249
13% 13%
2%
Net Profit 135 135
18% 18%
1%

In millions PLN.

Don't miss a Thing! We will send you all news about Neuca directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

NEUCA SA engages in the wholesale of pharmaceutical products. It operates through the following segments: Pharmaceutical Wholesale; Own Brands; and Outpatient Care Clinics, Clinical Trials, and Telemedicine. The Pharmaceutical Wholesale segment provides medical products for pharmacies. The Own Brands segment comprises market launching of pharmaceutical products under own brand. The Outpatient Care Clinics, Clinical Trials, and Telemedicine segment activities include general medical practice, clinical trials, and telemedicine. The company was founded by Kazimierz Michal Herba in 1990 and is headquartered in Torun, Poland.

Head office Poland
CEO Piotr Sucharski
Employees 4,633
Founded 1990
Website www.neuca.pl

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today